Mesalazine and extranodal marginal zone b-cell lymphoma (malt type) 
Mesalazine and extranodal marginal zone b-cell lymphoma (malt type) Patient Reports February 12, 2012
Mesalazine Side Effects Report #4961683-0
Mesalazine side effect was reported by a Consumer or non-health professional from SPAIN on Mar 23, 2006. Female patient, 79 years of age, was diagnosed with crohn's disease
and was treated with Mesalazine. After drug was administered, patient experienced the following side effects: extranodal marginal zone b-cell lymphoma (malt type). Mesalazine dosage: unknown. Patient recovered.Mesalazine Side Effects Report #4968710-5
Mesalazine side effect was reported by a Consumer or non-health professional from SPAIN on Mar 23, 2006. Female patient, 79 years of age, was diagnosed with crohn's disease
and was treated with Mesalazine. After drug was administered, patient experienced the following side effects: extranodal marginal zone b-cell lymphoma (malt type). Mesalazine dosage: DAILY DOSE: 3 MILLIGRAM(S) PER DAY. Patient recovered.